Compare ABEO & XRPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABEO | XRPN |
|---|---|---|
| Founded | 1974 | 2024 |
| Country | United States | United States |
| Employees | N/A | 2 |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.2M | 324.7M |
| IPO Year | 2005 | N/A |
| Metric | ABEO | XRPN |
|---|---|---|
| Price | $4.76 | $10.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 132.5K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.16 | N/A |
| EPS | ★ 1.01 | N/A |
| Revenue | ★ $2,998,000.00 | N/A |
| Revenue This Year | $1,276.65 | N/A |
| Revenue Next Year | $112.53 | N/A |
| P/E Ratio | ★ $4.77 | $72.74 |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $3.93 | $10.10 |
| 52 Week High | $7.54 | $10.35 |
| Indicator | ABEO | XRPN |
|---|---|---|
| Relative Strength Index (RSI) | 51.45 | 58.78 |
| Support Level | $4.53 | $10.26 |
| Resistance Level | $5.62 | N/A |
| Average True Range (ATR) | 0.20 | 0.02 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 71.53 | 85.57 |
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
Armada Acquisition Corp II is a blank check company.